{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T00:29:38Z","timestamp":1794011378811,"version":"4.8.0"},"reference-count":94,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.jceh.2021.12.010","type":"journal-article","created":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T20:46:54Z","timestamp":1640119614000},"page":"1360-1370","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Alcohol and Acute-on-Chronic Liver Failure"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7177-5696","authenticated-orcid":false,"given":"Maria Pilar","family":"Ballester","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Sittner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Jalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2021.12.010_bib1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/j.gastro.2014.05.005","article-title":"Toward an improved definition of acute-on-chronic liver failure","volume":"147","author":"Jalan","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2021.12.010_bib2","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1002\/hep.30056","article-title":"Acute-on-chronic liver failure: getting ready for prime-time","volume":"68","author":"Bajaj","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.12.010_bib3","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1056\/NEJMra1914900","article-title":"Acute-on-chronic liver failure","volume":"382","author":"Arroyo","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2021.12.010_bib4","doi-asserted-by":"crossref","first-page":"100176","DOI":"10.1016\/j.jhepr.2020.100176","article-title":"Acute-on-chronic liver failure: definitions, pathophysiology and principles of treatment","volume":"3","author":"Zaccherini","year":"2020","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jceh.2021.12.010_bib5","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/S0140-6736(15)00309-8","article-title":"Acute-on-chronic liver failure","volume":"386","author":"Bernal","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jceh.2021.12.010_bib6","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrgastro.2015.219","article-title":"Acute-on-chronic liver failure: terminology, mechanisms and management","volume":"13","author":"Sarin","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2021.12.010_bib7","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1136\/gutjnl-2016-312670","article-title":"Acute-on-chronic liver failure: an update","volume":"66","author":"Hernaez","year":"2017","journal-title":"Gut"},{"issue":"suppl 1","key":"10.1016\/j.jceh.2021.12.010_bib8","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1002\/cld.859","article-title":"Acute-on-chronic liver failure: a new disease or an old one hiding in plain sight?","volume":"15","author":"Jalan","year":"2020","journal-title":"Clin Liver Dis (Hoboken)"},{"issue":"suppl 1","key":"10.1016\/j.jceh.2021.12.010_bib9","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.jhep.2020.11.047","article-title":"Acute-on-chronic liver failure: a distinct clinical syndrome","volume":"75","author":"Moreau","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.12.010_bib10","article-title":"Global burden of disease: acute-on-chronic liver failure, a systematic review and meta-analysis","author":"Mezzano","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2021.12.010_bib11","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jhep.2018.12.008","article-title":"Acute-on-chronic liver failure in patients with alcohol-related liver disease","volume":"70","author":"Gustot","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.12.010_bib12","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s12072-008-9106-x","article-title":"Acute-On-Chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL)","volume":"3","author":"Sarin","year":"2009","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jceh.2021.12.010_bib13","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s12072-014-9580-2","article-title":"Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014","volume":"8","author":"Sarin","year":"2014","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jceh.2021.12.010_bib14","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s12072-019-09946-3","article-title":"Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL): an update","volume":"13","author":"Sarin","year":"2019","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jceh.2021.12.010_bib15","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/hep.27077","article-title":"Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures","volume":"60","author":"Bajaj","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.12.010_bib16","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1002\/hep.29773","article-title":"NACSELD acute-on-chronic liver failure (NACSELD-ACLF) score predicts 30-day survival in hospitalized patients with cirrhosis","volume":"67","author":"O'Leary","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.12.010_bib17","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","article-title":"Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis","volume":"144","author":"Moreau","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2021.12.010_bib18","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jhep.2014.06.012","article-title":"Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure","volume":"61","author":"Jalan","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.12.010_bib19","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jhep.2018.12.018","article-title":"Prevalence and short-term mortality of acute-on-chronic liver failure: a national cohort study from the USA","volume":"70","author":"Hernaez","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.12.010_bib20","doi-asserted-by":"crossref","first-page":"e0146745","DOI":"10.1371\/journal.pone.0146745","article-title":"Characteristics and discrepancies in acute-on-chronic liver failure: need for a unified definition","volume":"11","author":"Kim","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jceh.2021.12.010_bib21","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s12664-015-0574-3","article-title":"Acute-on-chronic liver failure: a prospective study to determine the clinical profile, outcome, and factors predicting mortality","volume":"34","author":"Amarapurkar","year":"2015","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.jceh.2021.12.010_bib22","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jhep.2018.03.018","article-title":"Electronic address: easloffice@easloffice.eu; European Association for the Study of the Liver. EASL clinical practice guidelines: management of alcohol-related liver disease","volume":"69","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.12.010_bib23","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1055\/s-2008-1040605","article-title":"Histologic spectrum of alcoholic liver disease","volume":"6","author":"MacSween","year":"1986","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jceh.2021.12.010_bib24","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1053\/j.gastro.2014.01.018","article-title":"A\u00a0histologic scoring system for prognosis of patients with alcoholic hepatitis","volume":"146","author":"Altamirano","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2021.12.010_bib25","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1053\/j.gastro.2016.02.042","article-title":"Standard definitions and common data elements for clinical trials in patients with alcoholic hepatitis: recommendation from the NIAAA alcoholic hepatitis consortia","volume":"150","author":"Crabb","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2021.12.010_bib26","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/hep.27779","article-title":"Systemic inflammatory response and serum lipopolysaccharide levels predict multiple organ failure and death in alcoholic hepatitis","volume":"62","author":"Michelena","year":"2015","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jceh.2021.12.010_bib27","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jhep.2018.02.022","article-title":"The prognostic value of acute-on-chronic liver failure during the course of severe alcoholic hepatitis","volume":"69","author":"Serst\u00e9","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.12.010_bib28","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1002\/hep.28812","article-title":"Time trends in the health care burden and mortality of acute on chronic liver failure in the United States","volume":"64","author":"Allen","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.12.010_bib29","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1002\/hep.28740","article-title":"Systemic inflammation in decompensated cirrhosis: characterization and role in acute-on-chronic liver failure","volume":"64","author":"Cl\u00e0ria","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.12.010_bib30","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1053\/j.gastro.2014.11.045","article-title":"Patients with acute-on-chronic liver failure have increased numbers of regulatory immune cells expressing the receptor tyrosine kinase MERTK","volume":"148","author":"Bernsmeier","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2021.12.010_bib31","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.jhep.2014.08.010","article-title":"Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance","volume":"61","author":"Albillos","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.12.010_bib32","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/j.cgh.2014.04.020","article-title":"Short-term and long-term causes of death in patients with alcoholic hepatitis in Denmark","volume":"12","author":"Orntoft","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2021.12.010_bib33","first-page":"152","article-title":"Infections in severe alcoholic hepatitis","volume":"30","author":"Karakike","year":"2017","journal-title":"Ann Gastroenterol"},{"key":"10.1016\/j.jceh.2021.12.010_bib34","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/hep.29581","article-title":"Cell death markers in patients with cirrhosis and acute decompensation","volume":"67","author":"Macdonald","year":"2018","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jceh.2021.12.010_bib35","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nature14191","article-title":"Necroptosis and its role in inflammation","volume":"517","author":"Pasparakis","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jceh.2021.12.010_bib36","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1002\/hep.29645","article-title":"Pyroptosis by caspase11\/4-gasdermin-D pathway in alcoholic hepatitis in mice and patients","volume":"67","author":"Khanova","year":"2018","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jceh.2021.12.010_bib37","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nrgastro.2015.35","article-title":"Alcoholic liver disease: mechanisms of injury and targeted treatment","volume":"12","author":"Louvet","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2021.12.010_bib38","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1136\/gutjnl-2017-314240","article-title":"Bacterial and fungal infections in acute on-chronic liver failure: prevalence, characteristics and impact on prognosis","volume":"67","author":"Fern\u00e1ndez","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2021.12.010_bib39","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1056\/NEJMra0805786","article-title":"Alcoholic hepatitis","volume":"360","author":"Lucey","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.jceh.2021.12.010_bib40","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jhep.2020.01.011","article-title":"Toll-like receptor 4 is a therapeutic target for prevention and treatment of liver failure","volume":"73","author":"Engelmann","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.12.010_bib41","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1080\/08830185.2017.1380200","article-title":"Toll-like receptors: significance, ligands, signaling pathways, and functions in mammals","volume":"37","author":"Idya","year":"2018","journal-title":"Int Rev Immunol"},{"key":"10.1016\/j.jceh.2021.12.010_bib42","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00441-007-0542-z","article-title":"Activation of stem cells in hepatic diseases","volume":"331","author":"Bird","year":"2008","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.jceh.2021.12.010_bib43","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/liv.12356","article-title":"Beneficial role of G-CSF in acute-on-chronic liver failure: effects on liver regeneration, inflammation\/immunoparalysis or both?","volume":"34","author":"Gustot","year":"2014","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2021.12.010_bib44","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jhep.2014.04.012","article-title":"Human serum albumin, systemic inflammation, and cirrhosis","volume":"61","author":"Arroyo","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.12.010_bib45","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1136\/gutjnl-2019-318843","article-title":"Albumin in decompensated cirrhosis: new concepts and perspectives","volume":"69","author":"Bernardi","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2021.12.010_bib46","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMra0809139","article-title":"Renal failure in cirrhosis","volume":"361","author":"Gin\u00e8s","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2021.12.010_bib47","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/j.cgh.2018.01.035","article-title":"Association between grade of acute on chronic liver failure and response to terlipressin and albumin in patients with hepatorenal syndrome","volume":"16","author":"Piano","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2021.12.010_bib48","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1056\/NEJMra1208623","article-title":"Severe sepsis and septic shock","volume":"369","author":"Angus","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2021.12.010_bib49","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.jhep.2019.11.009","article-title":"Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF","volume":"72","author":"Moreau","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.12.010_bib50","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s12072-017-9816-z","article-title":"Liver failure determines the outcome in patients of acute-on-chronic liver failure (ACLF): comparison of APASL ACLF Research Consortium (AARC) and CLIF-SOFA models","volume":"11","author":"Choudhury","year":"2017","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jceh.2021.12.010_bib51","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.14309\/ajg.0000000000000771","article-title":"The Use of NACSELD and EASL-CLIF classification systems of ACLF in the prediction of prognosis in hospitalized patients with cirrhosis","volume":"115","author":"Cao","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2021.12.010_bib52","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1111\/apt.14046","article-title":"A\u00a0nomogram for predicting prognostic value of inflammatory response biomarkers in decompensated cirrhotic patients without acute-on-chronic liver failure","volume":"45","author":"Cai","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2021.12.010_bib53","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/apt.14183","article-title":"Letter: there's something about the Neutrophil-to-Lymphocyte ratio (NLR)\u2026","volume":"46","author":"Forrest","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2021.12.010_bib54","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.jhep.2020.06.013","article-title":"The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology","volume":"73","author":"Trebicka","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.12.010_bib55","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0016-5085(78)90401-8","article-title":"Corticosteroid therapy of alcoholic hepatitis","volume":"75","author":"Maddrey","year":"1978","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2021.12.010_bib56","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1136\/gut.2004.050781","article-title":"Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score","volume":"54","author":"Forrest","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2021.12.010_bib57","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1111\/j.1572-0241.2008.02104.x","article-title":"A\u00a0new scoring system for prognostic stratification of patients with alcoholic hepatitis","volume":"103","author":"Dominguez","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2021.12.010_bib58","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/hep.27849","article-title":"Clinical course of acute-on-chronic liver failure syndrome and effects on prognosis","volume":"62","author":"Gustot","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.12.010_bib59","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1097\/CCM.0000000000003369","article-title":"Chronic liver failure consortium and European Foundation for the study of chronic liver failure. Dynamic prognostication in critically ill cirrhotic patients with multiorgan failure in ICUs in Europe and North America: a multicenter analysis","volume":"46","author":"Karvellas","year":"2018","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jceh.2021.12.010_bib60","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/hep.21607","article-title":"The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids","volume":"45","author":"Louvet","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.12.010_bib61","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/gut.2010.224097","article-title":"Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data","volume":"60","author":"Mathurin","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2021.12.010_bib62","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1053\/j.gastro.2018.12.007","article-title":"Factors associated with survival of patients with severe acute-on-chronic liver failure before and after liver transplantation","volume":"156","author":"Sundaram","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2021.12.010_bib63","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1053\/j.gastro.2018.08.026","article-title":"Effects of long-term norfloxacin therapy in patients with advanced cirrhosis","volume":"155","author":"Moreau","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2021.12.010_bib64","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa0907893","article-title":"Rifaximin treatment in hepatic encephalopathy","volume":"362","author":"Bass","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2021.12.010_bib65","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1053\/j.gastro.2011.12.056","article-title":"Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure","volume":"142","author":"Kribben","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2021.12.010_bib66","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/hep.26185","article-title":"Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial","volume":"57","author":"Ba\u00f1ares","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.12.010_bib67","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/lt.24986","article-title":"Extracorporeal cellular therapy (ELAD) in severe alcoholic hepatitis: a multinational, prospective, controlled, randomized trial","volume":"24","author":"Thompson","year":"2018","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jceh.2021.12.010_bib68","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1053\/j.gastro.2016.02.074","article-title":"Treatment of severe alcoholic hepatitis","volume":"150","author":"Thursz","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2021.12.010_bib69","doi-asserted-by":"crossref","first-page":"685","DOI":"10.7326\/0003-4819-110-9-685","article-title":"Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial","volume":"110","author":"Carithers","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jceh.2021.12.010_bib70","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1053\/gast.1996.v110.pm8964410","article-title":"Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone","volume":"110","author":"Mathurin","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2021.12.010_bib71","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1056\/NEJMc1506342","article-title":"Prednisolone or pentoxifylline for alcoholic hepatitis","volume":"373","author":"Verbeke","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2021.12.010_bib72","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/0016-5085(80)90867-7","article-title":"Double-blind controlled trial of prednisolone therapy in patients with severe acute alcoholic hepatitis and spontaneous encephalopathy","volume":"78","author":"Depew","year":"1980","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2021.12.010_bib73","doi-asserted-by":"crossref","first-page":"810","DOI":"10.4103\/2141-9248.141562","article-title":"Pentoxifylline plus prednisolone versus pentoxifylline only for severe alcoholic hepatitis: a randomized controlled clinical trial","volume":"4","author":"De","year":"2014","journal-title":"Ann Med Health Sci Res"},{"key":"10.1016\/j.jceh.2021.12.010_bib74","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/gut.23.1.75","article-title":"Controlled trial of methylprednisolone therapy in severe acute alcoholic hepatitis","volume":"23","author":"Theodossi","year":"1982","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2021.12.010_bib75","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.jhep.2005.11.039","article-title":"Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis\u2013a randomised clinical trial","volume":"44","author":"Phillips","year":"2006","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.12.010_bib76","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.jhep.2010.05.030","article-title":"Enteral nutrition with or without N-acetylcysteine in the treatment of severe acute alcoholic hepatitis: a randomized multicenter controlled trial","volume":"53","author":"Moreno","year":"2010","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.12.010_bib77","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMoa1101214","article-title":"Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis","volume":"365","author":"Nguyen-Khac","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2021.12.010_bib78","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1124\/mol.110.068064","article-title":"TAK-242 (resatorvid), a small-molecule inhibitor of Toll-like receptor (TLR) 4 signaling, binds selectively to TLR4 and interferes with interactions between TLR4 and its adaptor molecules","volume":"79","author":"Matsunaga","year":"2011","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jceh.2021.12.010_bib79","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1097\/CCM.0b013e3181e7c5c9","article-title":"A\u00a0randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis","volume":"38","author":"Rice","year":"2010","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jceh.2021.12.010_bib80","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/hep.20206","article-title":"A\u00a0double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis","volume":"39","author":"Naveau","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.12.010_bib81","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jhep.2019.11.013","article-title":"Interleukin-22 ameliorates acute-on-chronic liver failure by reprogramming impaired regeneration pathways in mice","volume":"72","author":"Xiang","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.12.010_bib82","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/hep.31046","article-title":"An open label, dose escalation study to assess the safety and efficacy of IL-22 agonist F-652 in patients with alcoholic hepatitis","volume":"72","author":"Arab","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.12.010_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2021.07.033","article-title":"Granulocyte-Colony Stimulating Factor (G-CSF) to treat acute-on-chronic liver failure, a multicenter randomized trial (GRAFT study)","author":"Engelmann","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.12.010_bib84","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S2468-1253(17)30326-6","article-title":"Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial","volume":"3","author":"Newsome","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2021.12.010_bib85","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jceh.2019.05.003","article-title":"Granulocyte colony-stimulating factor use in decompensated cirrhosis: lack of survival benefit","volume":"10","author":"Philips","year":"2020","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2021.12.010_bib86","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1055\/s-0041-1723034","article-title":"The current status of granulocyte-colony stimulating factor to treat acute-on-chronic liver failure","volume":"41","author":"Engelmann","year":"2021","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jceh.2021.12.010_bib87","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.cgh.2016.10.029","article-title":"Healthy donor fecal microbiota transplantation in steroid-ineligible severe alcoholic hepatitis: a pilot study","volume":"15","author":"Philips","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2021.12.010_bib88","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.coph.2021.06.011","article-title":"Treatment of severe alcoholic hepatitis: a systematic review","volume":"60","author":"Van Melkebeke","year":"2021","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.jceh.2021.12.010_bib89","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.jhep.2017.06.009","article-title":"Liver transplantation in the most severely ill cirrhotic patients: a multicenter study in acute-on-chronic liver failure grade 3","volume":"67","author":"Artru","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.12.010_bib90","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jhep.2018.07.007","article-title":"Liver transplantation in patients with multiple organ failures: feasibility and outcomes","volume":"69","author":"Thuluvath","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.12.010_bib91","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1056\/NEJMoa1105703","article-title":"Early liver transplantation for severe alcoholic hepatitis","volume":"365","author":"Mathurin","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2021.12.010_bib92","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1053\/j.gastro.2018.04.009","article-title":"Outcomes of early liver transplantation for patients with severe alcoholic hepatitis","volume":"155","author":"Lee","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2021.12.010_bib93","first-page":"e213748","article-title":"Evaluation of early vs standard liver transplant for alcohol-associated liver disease","author":"Herrick-Reynolds","year":"2021","journal-title":"JAMA Surg"},{"key":"10.1016\/j.jceh.2021.12.010_bib94","first-page":"3867","article-title":"New indications for liver transplantation","volume":"10","author":"Zanetto","year":"2021","journal-title":"J\u00a0Clin Med"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S097368832100596X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S097368832100596X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:08:42Z","timestamp":1760854122000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S097368832100596X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":94,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S097368832100596X"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2021.12.010","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alcohol and Acute-on-Chronic Liver Failure","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2021.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}